IP Library Granted Patent US 11,040,139
Granted Patent B2
US 11,040,139 · App. 16/781,146 · Granted Jun 22, 2021

Drug delivery systems with sealed and sterile fluid paths and methods of providing the same

Inventor: Ian McLaughlin (Groton, MA)
Assignee: INSULET CORPORATION
A61M5/16827A61L2/00A61L2/087A61M5/162A61M5/2466A61L2/07A61L2/081A61L2/082A61L2/206A61L2202/23A61M5/001A61M5/14566A61M5/19A61M2005/3118A61M2005/3132A61M2005/3258A61M2039/1072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,040,139
App. No.
16/781,146
Granted
Jun 22, 2021
Kind
B2
Abstract

The present disclosure relates generally to the field of drug delivery. In particular, the present disclosure relates to a drug delivery system that includes a sealed and sterile fluid path attached to a drug-loaded container. The disclosure further relates to methods for sterilizing a portion of the drug delivery system without exposing the drug-loaded container to harmful sterilization parameters.

Claims (29)

1. A method, comprising:

providing an energy source and a drug delivery system; and

positioning a shield between the energy source and the drug delivery system, the drug delivery system comprising a container, a fluid path, and a cover, wherein the container holds a liquid drug, wherein a first end of the fluid path is disposed within the container, and wherein a second end of the fluid path is disposed within the cover.

2. The method of claim 1 , further comprising:

emitting energy from the energy source;

sterilizing the fluid path by exposing the fluid path to the energy emitted by the energy source; and

blocking exposure of the liquid drug to a substantial portion of the energy emitted by the energy source.

3. The method of claim 2 , further comprising sterilizing the liquid drug prior to sterilizing the fluid path.

4. The method of claim 1 , wherein positioning the shield comprises positioning an aluminum shield having a thickness of at least 30 mm between the drug delivery system and the energy source.

5. The method of claim 1 , further comprising piercing a cap sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path.

6. The method of claim 1 , further comprising piercing a septum sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path.

7. The method of claim 1 , further comprising piercing a plunger sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path.

8. The method of claim 1 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component.

9. A method for sterilizing a liquid drug in a drug delivery system, comprising:

positioning a shield between an energy source and the drug delivery system, the drug delivery system comprising a fluid path and a container holding the liquid drug; and

exposing the fluid path to an energy emitted by the energy source, wherein the shield blocks exposure of the liquid drug to at least a portion of the energy.

10. The method of claim 9 , further comprising sterilizing the liquid drug prior to sterilizing the fluid path.

11. The method of claim 9 , wherein positioning the shield comprises positioning an aluminum shield having a thickness of at least 30 mm between the drug delivery system and the energy source.

12. The method of claim 9 , further comprising piercing a cap sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user.

13. The method of claim 9 , further comprising piercing a septum sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user.

14. The method of claim 9 , further comprising piercing a plunger sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user.

15. The method of claim 9 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component.

16. A method, comprising:

positioning a shield between an energy source and a drug delivery system, the drug delivery system comprising a fluid path for accessing a liquid drug within a container; and

exposing the fluid path to an energy emitted by the energy source, wherein the shield blocks exposure of the liquid drug to at least a portion of the energy.

17. The method of claim 16 , further comprising blocking exposure, by the energy emitted from the energy source, of an entire portion of the container and at least a portion of a cap inserted within the container.

18. The method of claim 17 , further comprising piercing the cap with the fluid path to couple the liquid drug to the fluid path upon activation by a user.

19. The method of claim 16 , further comprising exposing an entire portion of the fluid path to the energy emitted by the energy source.

20. The method of claim 16 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component.

Assignments (2)
SECURITY INTEREST Recorded May 4, 2021
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 056135/0974 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2020
From: MCLAUGHLIN, IAN
To: INSULET CORPORATION
Reel/Frame 051739/0433 →